Hospital Ruber Internacional-ko ikertzaileekin lankidetzan egindako argitalpenak (91)

2024

  1. Clinical practice guideline on the management of vestibular schwannoma

    Acta Otorrinolaringologica Espanola, Vol. 75, Núm. 2, pp. 108-128

  2. Efficacy and tolerability of add-on stiripentol in real-world clinical practice: An observational study in Dravet syndrome and non-Dravet developmental and epileptic encephalopathies

    Epilepsia Open, Vol. 9, Núm. 1, pp. 164-175

  3. Melanoma Registry of the Spanish Academy of Dermatology and Venereology (REGESMEL): Description and Data in its First Year of Operation

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 7, pp. 663-669

2023

  1. Hemihypomimia in Parkinson’s disease: an under-recognized clinical sign?

    Journal of Neurology

  2. Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 1-25

  3. Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors

    Biomedicines, Vol. 11, Núm. 4

  4. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

2022

  1. Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy

    Epilepsy and Behavior, Vol. 137

  2. Stereoelectroencephalography in the preoperative assessment of patients with refractory focal epilepsy: Experience at an epilepsy centre

    Neurologia, Vol. 37, Núm. 5, pp. 334-345

  3. The Charlotte Project: Recommendations for patient-reported outcomes and clinical parameters in Dravet syndrome through a qualitative and Delphi consensus study

    Frontiers in Neurology, Vol. 13

2021

  1. Cannabidiol for the treatment of lennox-gastaut syndrome and dravet syndrome: Experts' recommendations for its use in clinical practice in spain

    Revista de Neurologia, Vol. 73, Núm. S01, pp. S1-S8

  2. Epilepsy Associated with Temporal Pole Encephaloceles: An Unrecognized Manifestation of Idiopathic Intracranial Hypertension?

    Clinical Neuroradiology, Vol. 31, Núm. 3, pp. 575-579

  3. Variable immunodeficiency score upfront analytical link (VISUAL), a proposal for combined prognostic score at diagnosis of common variable immunodeficiency

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Diagnostic gap in genetic epilepsies: A matter of age

    Epilepsy and Behavior, Vol. 111

  2. Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial

    JAMA Neurology

  3. Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: Experience from a national multicenter registry

    Epilepsia, Vol. 61, Núm. 6, pp. 1109-1119

  4. Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine

    Neurologia, Vol. 35, Núm. 8, pp. 568-578

  5. Fenfluramine for Treatment-Resistant Seizures in Patients with Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial

    JAMA Neurology, Vol. 77, Núm. 3, pp. 300-308

  6. Impact of the Coronavirus Disease 2019 Pandemic on Functional Movement Disorders: Lessons From a Specialized Clinic

    Movement Disorders

  7. Morphometric correlates of anomia in patients with small left temporopolar lesions

    Journal of Neuropsychology, Vol. 14, Núm. 2, pp. 260-282